Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients

International Journal of Cardiology

Volumn 59, Issue 3, 1997, Pages 285-289

  Cardoso, José Silva ^a,b   Mota Miranda, António ^a   Conde, Cecília ^a   Moura, Brenda ^a   Rocha Gonçalves, Francisco ^a   Lecour, Henrique ^a  

^a Porto School of Nursing   (Portugal)

^b NONE   (Portugal)

Author keywords

AIDS; Inhalatory pentamidine; QT interval prolongation

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; PENTAMIDINE ISETHIONATE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; QT INTERVAL; TORSADE DES POINTES;

ADMINISTRATION, INHALATION; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; TORSADES DE POINTES;

EID: 0031003640     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)02968-9     Document Type: Article

References (18)

1. Cardoso J, Mota-Miranda A, Conde C et al. Inhalatory pentamidine therapy and QT interval in human immunodeficiency virus infected patients [abstract]. Eur Heart J 1995; 15 Suppl: 248.
2. Cardoso J, Mota-Miranda A, Cruz A et al. Dysrhythmic profile of human immunodeficiency virus infected patients. Int J Cardiol 1995; 49: 249-255.
3. Wharton JM, Demopulos PA, Goldschlager N. Torsades de pointes during administration of pentamidine isethionate. Am J Med 1987; 83: 571-575.
4. Mitchell P, Dodek P, Lawson L, Kiess M, Russell J. Torsades de pointes during intravenous pentamidine isethionate therapy. Can Med Assoc J 1989; 140: 173-174.
5. Pujol M, Carratala J, Mavel J, Viladrich PF. Ventricular tachycardia due to pentamidine isethionate. Am J Med 1988; 84: 980.
6. Bibler MR, Chou TC, Toltzis RJ, Wade PA. Recurrent ventricular tachycardia due to pentamidine induced cardiotoxicity. Chest 1988; 94: 1303-1306.
7. Stein KM, Haronian H, Mensah GA, Acosta A, Jacobs J, Kligfield P. Ventricular tachycardia and torsades de pointes complicating pentamidine therapy of Pneumocystis carinii in the acquired immune deficiency syndrome. Am J Cardiol 1990; 66(10): 888-889.
8. Gonzalez A, Sager PT, Akil B, Rahimtoola SH, Bhandari AK. Pentamidine-induced torsades de pointes. Am Heart J 1991; 122(5): 1489-1492.
9. Cortese LM, Gasser RA Jr, Bjornson DC, Dacey MJ, Oster CN. Prolonged recurrence of pentamidine-induced torsades de pointes. Ann Pharmacother 1992; 26(11): 1365-1369.
10. Balslev U, Berild D, Nielsen TL. Cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate. Scand J Infect Dis. 1992; 24(1): 111-112.
11. Eisenhauer MD, Eliason AH, Taylor AJ, Coyne Jr PE, Wortham DC. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest 1994; 105(2): 389-395.
12. Taylor AJ, Hull RW, Coyne PE, Woosley RL, Eliasson AH. Pentamidine-induced torsades de pointes: safe completion of therapy with inhaled pentamidine. Clin Pharmacol Ther 1991; 49: 698-700.
13. Moss AJ, Behnorin J. QT interval prolongation: basic considerations and clinical consequences. In: Braunwald (editor). Heart Disease - Update 20. Philadelphia, PA: W.B. Saunders 1993; 453-461.
14. Webster TL. In: Gilman AG, Rall TW, Nies AS, Taylor P (editors). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Mcgraw-Hill, 1991; 1011-1013.
15. Bazzet HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353-370.
16. Conte JE Jr, Hollander H, Golden JA. Inhaled or reduced-dose intravenous pentamidine for Pneumocistis carinii pneumonia. Ann Intern Med 1987; 107: 495-498.
17. Hughes WT. In: Mandel GL, Douglas RG (editors). Principles and Practice of Infectious Diseases. New York: John Wiley & Sons, 1978; 1549-1552.
18. Thalhammer C, Bogner JR, Lohmoller G. Chronic pentamidine aerosol prophylaxis does not induce QT prolongation. Clin Invest 1993; 71(4): 319-322.